PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
CSF2/GM-CSF 2 Target Disease Infection 766,637 1 0.00 -0.71 0.50 0.57
Adp/Atp Translocase 3 2 Target Disease Breast Cancer 173,695 1 0.00 -0.71 0.50 0.60
Atp-Binding Cassette Sub-Family G Member 1 2 Target Disease Liver Disease 49,817 1 0.00 -0.71 0.50 0.62
Renin 43,456 Target Disease Hypertension (High Blood Pressure) 2 1 0.00 -0.71 0.50 0.62
CD4 112,219 Target Drug Actemra (Tocilizumab Injection)- FDA 2 1 0.00 -0.71 0.50 0.60
Alpha-Glucosidase 4,319 Target Drug Alglucosidase Alfa (Myozyme)- FDA 4 2 0.02 -0.71 0.50 0.69
C7 7,027 Target Drug Kadangustin J 2 1 0.01 -0.71 0.50 0.67
CD4 112,219 Target Target Ck-beta-11 4 2 0.00 -0.71 0.50 0.61
ADRBK2 8 Target Target Beta-Adrenergic Receptor Kinase 2 15 4 0.37 -0.61 0.50 0.93
BNP 6,842 Target Target Brain (B-type) Natriuretic Protein 8 4 0.02 -0.71 0.50 0.69
EPHB3 118 Target Target EPHB2 385 59 0.28 -0.65 0.50 0.88
CRG-2 41 Target Target CRG-10 2 1 0.11 -0.70 0.50 0.83
Epigen 27 Target Target EGF 27,487 14 0.02 -0.69 0.52 0.67
ANGPT1 81 Target Target ANGPT2 105 42 0.46 -0.54 0.52 0.94
CCL19 658 Target Target CCL21 808 344 0.47 -0.52 0.52 0.93
Eotaxin-3/CCL26 26 Target Target Eotaxin-2/CCL24 19 10 0.45 -0.54 0.53 0.94
Cytokeratin 20 847 Target Disease Carcinoma 433,099 449 0.02 -0.69 0.53 0.63
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Cancer 1,053,491 21 0.00 -0.68 0.54 0.58
ERK1 18,374 Target Target ERK2 3,287 1,788 0.23 -0.64 0.54 0.82
Epidermal Growth Factor Receptor 24,772 Target Disease Cancer 1,053,491 13,587 0.08 -0.67 0.55 0.66
CD4 112,219 Target Target CD254 9 5 0.00 -0.67 0.56 0.62
CXCL10 2,386 Target Target CXCL4/PF4 9 5 0.03 -0.67 0.56 0.72
Epiregulin 291 Target Target EGF 27,487 162 0.06 -0.66 0.56 0.71
CXCL9 1,016 Target Target CXCL11 526 293 0.40 -0.56 0.56 0.91
CXCL3 145 Target Target CXCL2 750 81 0.25 -0.63 0.56 0.86
AKT2 873 Target Target AKT3 293 164 0.32 -0.60 0.56 0.88
CA125 Antigen 78 Target Disease Ovarian Cancer 33,996 45 0.03 -0.65 0.58 0.68
DDR2 194 Target Target Collagen 138,882 113 0.02 -0.65 0.58 0.65
CEA 17,022 Target Target CA 72-4 184 108 0.06 -0.64 0.59 0.72
CCL7 274 Target Target CCL2 3,560 164 0.17 -0.62 0.60 0.81
Adenosine Deaminase 6,613 Target Target ADAT1 5 3 0.02 -0.63 0.60 0.69
ATAC 239 Target Disease Breast Cancer 173,695 144 0.02 -0.63 0.60 0.65
APOA1 958 Target Disease Cholesterol 182,390 585 0.04 -0.62 0.61 0.67
Cathepsin G 1,613 Target Target Elastase 13,875 985 0.21 -0.60 0.61 0.81
Erbb2 4,536 Target Target ERBB3 1,154 711 0.31 -0.57 0.62 0.86
ATAC 239 Target Disease Cancer 1,053,491 148 0.01 -0.62 0.62 0.59
CA 15-3 898 Target Disease Breast Cancer 173,695 557 0.04 -0.62 0.62 0.67
ELC 355 Target Target Exodus-3 8 5 0.09 -0.61 0.62 0.79
APOE 12,771 Target Target APOC1 126 82 0.06 -0.59 0.65 0.73
CXCL9 1,016 Target Target CXCL10 2,386 676 0.43 -0.49 0.67 0.90
Xanthine Oxidase 8,860 Target Drug Anturane (Sulfinpyrazone)- FDA 3 2 0.01 -0.58 0.67 0.67
ApoE2 517 Target Target ApoE4 1,525 348 0.39 -0.50 0.67 0.89
Ns3 3,189 Target Disease Hepatitis 163,842 2,173 0.10 -0.56 0.68 0.71
CA125 Antigen 78 Target Disease Cancer 1,053,491 54 0.01 -0.55 0.69 0.59
Alpha-Amylase 7,171 Target Target AMY1A 13 9 0.03 -0.55 0.69 0.70
CD14 9,941 Target Target Endotoxin receptor 115 80 0.07 -0.55 0.70 0.74
Calmodulin 25,240 Target Target CAMK4 43 30 0.03 -0.55 0.70 0.69
CXCL11 526 Target Target CXCL10 2,386 369 0.33 -0.50 0.70 0.87
ACRP30 102 Target Target Adiponectin 11,994 72 0.07 -0.54 0.71 0.73
EGF 27,487 Target Target beta-Cellulin 17 12 0.02 -0.54 0.71 0.67